Riccardo Autorino, MD, PhD, FEBU, presented “Radical Prostatectomy for Oligometastatic Prostate Cancer: Is There Any Benefit?” at the Jackson Hole Seminars on February 7, 2018 in Jackson Hole, Wyoming.

How to cite: Autorino, Riccardo. “Radical Prostatectomy for Oligometastatic Prostate Cancer: Is There Any Benefit?”   February 7, 2018. Accessed Jan 2026. https://grandroundsinurology.com/Radical-Prostatectomy-for-Oligometastatic-Prostate-Cancer/

Radical Prostatectomy for Oligometastatic Prostate Cancer: Is There Any Benefit?

Summary:

Riccardo Autorino, MD, PhD, FEBU, defines oligometastatic prostate cancer, a newly-explored concept in the urological community. He discusses whether or not radical prostatectomy offers significant oncological benefits that outweigh the risk of complications and negative impacts on urinary function and quality of life outcomes for patients in this stage.

<script type="application/ld+json"><!-- [et_pb_line_break_holder] -->{<!-- [et_pb_line_break_holder] -->"@context": "http://schema.org",<!-- [et_pb_line_break_holder] -->"@type": "VideoObject",<!-- [et_pb_line_break_holder] -->"name": "Radical Prostatectomy for Oligometastatic Prostate Cancer: Is There Any Benefit?",<!-- [et_pb_line_break_holder] -->"description": "Riccardo Autorino, MD, PhD, FEBU, defines oligometastatic prostate cancer, a newly-explored concept in the urological community. He discusses whether or not radical prostatectomy offers significant oncological benefits that outweigh the risk of complications and negative impacts on urinary function and QOL outcomes for patients in this stage.",<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->"thumbnailUrl": "https://grandroundsinurology.com/wp-content/uploads/2018/05/Radical-Prostatectomy-for-Oligometastatic-Prostate-Cancer-copy-2.png",<!-- [et_pb_line_break_holder] -->"uploadDate": "2018-05-23",<!-- [et_pb_line_break_holder] -->"duration": "17:41",<!-- [et_pb_line_break_holder] -->"publisher": {<!-- [et_pb_line_break_holder] --> "@type": "Organization",<!-- [et_pb_line_break_holder] --> "name": "Grand Rounds in Urology",<!-- [et_pb_line_break_holder] -->"logo": {<!-- [et_pb_line_break_holder] --> "@type": "ImageObject",<!-- [et_pb_line_break_holder] -->"url": "https://grandroundsinurology.com/wp-content/uploads/2016/11/GRU_WebMedium-e1480706258120.jpg"<!-- [et_pb_line_break_holder] -->}<!-- [et_pb_line_break_holder] -->},<!-- [et_pb_line_break_holder] -->"embedUrl": "https://player.vimeo.com/video/271541787" <!-- [et_pb_line_break_holder] -->}<!-- [et_pb_line_break_holder] --></script>

ABOUT THE AUTHOR

+ posts

Riccardo Autorino, MD, PhD, FEBU, is the Director of Clinical Outcomes Research for the Glickman Urological and Kidney Institute at the Cleveland Clinic in Cleveland, Ohio.His main clinical interest is the minimally-invasive treatment of urologic cancers and benign urologic diseases using robotic-assisted surgery.